kabutan
N225

57,434.77

-5.96%

TOPIX

3,707.99

-5.90%

USDJPY

158.05

+0.16%

TERUMO CORPORATION(4543) Summary

4543
TSE Prime
TERUMO CORPORATION
Result
ー
2,500.5
JPY
-127.0
(-4.83%)
Nov 6, 3:30 pm JST
15.83
USD
Nov 6, 1:30 am EST
PER
30.7
PBR
2.22
Yield
1.44%
Margin Trading Ratio
3.34
PTS
outside of trading hours
ー
ー
Stock Price
Nov 6, 2026
Opening Nov 6, 9:00 am
2,597.0 JPY 16.48 USD
Previous Close Nov 5
2,627.5 JPY 16.64 USD
High Nov 6, 9:49 am
2,627.0 JPY 16.66 USD
Low Nov 6, 3:14 pm
2,480.0 JPY 15.71 USD
Volume
8,714,500
Trading Value
0.02T JPY 0.14B USD
VWAP
2542.79 JPY 16.1 USD
Minimum Trading Value
250,050 JPY 1,583 USD
Market Capitalization
3.70T JPY 0.02T USD
Number of Trades
21,515
Liquidity & Number of Trades
As of Nov 6, 2026
Liquidity
High
1-Year Average
8,315
1-Year High Nov 6, 2026
21,515
Margin Trading
Date Short Interest Long Margin Positions Ratio
Oct 30, 2026 127,100 424,800 3.34
Oct 23, 2026 131,700 496,600 3.77
Oct 16, 2026 128,800 515,300 4.00
Oct 9, 2026 128,100 663,400 5.18
Oct 2, 2026 117,200 815,700 6.96
Company Profile
TERUMO CORPORATION is a leading manufacturer of medical devices, with a strong presence in the cardiovascular field. The company holds a high global market share in catheters and heart-lung machines.
TERUMO CORPORATION is a major medical device manufacturer with its business divided into three segments: "Cardiac and Vascular Company," "Medical Care Solutions Company," and "Blood and Cell Technologies Company." The group consists of numerous consolidated subsidiaries and equity-method affiliates, operating globally with an overseas sales ratio approaching 80%. The company offers a wide range of products across various business fields, with a particular strength in cardiovascular care, providing comprehensive solutions to meet the needs of medical professionals.